Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Modulight's enterprise value is €39.49 Mil.
Modulight's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €1.05 Mil. Therefore, Modulight's EV-to-EBITDA for today is 37.68.
The historical rank and industry rank for Modulight's EV-to-EBITDA or its related term are showing as below:
FRA:78W'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -390.2 Med: -7.7 Max: 382.03
Current: 37.68
During the past 8 years, the highest EV-to-EBITDA of Modulight was 382.03. The lowest was -390.20. And the median was -7.70.
FRA:78W's EV-to-EBITDA is ranked worse than 84.5% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.67
vs FRA:78W: 37.68
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Modulight's share price for today is €1.08.
Modulight's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.100.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Modulight's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Modulight's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modulight EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Modulight's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Modulight's EV-to-EBITDA falls into.
Modulight's current Enterprise Value is €39.49 Mil.
Modulight's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modulight (FRA:78W) has a EV-to-EBITDA of 37.68 as of Aug. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Modulight. According to the industry distribution chart, Modulight ranks #436 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 84.5%.
Is Modulight's EV-to-EBITDA too high?
Modulight's current EV-to-EBITDA is 37.68. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.67. Modulight's value of 37.68 is 156.9% above this industry median. Based on the distribution chart, Modulight ranks #436 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Modulight has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Modulight's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Modulight ranks #436 out of 516 companies for EV-to-EBITDA. This places Modulight in the lower half of its industry. The industry median EV-to-EBITDA is 14.67. Modulight's value of 37.68 is 156.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.67, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modulight's current EV-to-EBITDA of 37.68 is 156.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Modulight. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modulight's current EV-to-EBITDA is 37.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modulight stock overvalued right now?
Modulight (FRA:78W) has a current EV-to-EBITDA of 37.68. The stock's GF Value™ is €1.83, compared to a current price of €1.08 — trading 41% below its estimated fair value. The current EV-to-EBITDA is 37.68 and 156.9% above the Medical Devices & Instruments industry median of 14.67. Modulight's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Modulight (FRA:78W), the current EV-to-EBITDA is 37.68 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Modulight (FRA:78W) Overvalued in 2026?
Based on GuruFocus' analysis, Modulight stock appears to be undervalued.
The current stock price of €1.08 is trading 41% below its estimated GF Value™ of €1.83.
Key valuation signals for FRA:78W:
EV-to-EBITDA: 37.68
GF Value™: €1.83 vs. price of €1.08 (41% below fair value)
Industry Position: 156.9% above the Medical Devices & Instruments median (#436 of 516)
No single metric tells the full story. See the FRA:78W stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Modulight Corp is a biomedical company that designs and manufactures laser devices for the treatment of cancer, eye diseases, and for genetics. The company also manufactures products for other high-value-added applications such as flow cytometry, microscopy, semiconductors, quantum, and defense. The company provides biomedical lasers for oncology, genetics, and ophthalmology, supporting laser solutions like system integration service and laser design & manufacturing.
70GF Score
Get the complete analysis for FRA:78W
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:78W has been successfully added to your 
